When Fast Means Faulty

gan Furman, Richard R.
Cyhoeddwyd yn Gastroenterol Hepatol (N Y) (2020)

Current trends in the management of Richter's syndrome

gan Allan, John N, Furman, Richard R
Cyhoeddwyd yn Int J Hematol Oncol (2019)

NK/T cell non-Hodgkin lymphoma in a HIV-positive patient

gan Panarelli, Nicole C., Furman, Richard R., Wang, Y. Lynn, Elstrom, Rebecca, Cohen, Jules A., Chadburn, Amy
Cyhoeddwyd 2010

Extracorporeal Membrane Oxygenation as a Bridge to Chemotherapy in an Orthodox Jewish Patient

gan Meltzer, Ellen C., Ivascu, Natalia S., Acres, Cathleen A., Stark, Meredith, Furman, Richard R., Fins, Joseph J.
Cyhoeddwyd 2014

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease: A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

gan Gordon, Jessica K., Magro, Cynthia, Lu, Theresa, Schneider, Robert, Chiu, April, Furman, Richard R., Solomon, Garron, Bass, Anne, Erkan, Doruk
Cyhoeddwyd 2009

Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

gan Stein, Rhona, Gupta, Pankaj, Chen, Xiaochuan, Cardillo, Thomas M., Furman, Richard R., Chen, Susan, Chang, Chien-Hsing, Goldenberg, David M.
Cyhoeddwyd 2010

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

gan Islam Naziba, Broekman M Johan, Olson Kim E, Pulte Dianne, Ballard Harold S, Furman Richard R, Olson Ashley E, Marcus Aaron J
Cyhoeddwyd 2007-05-01

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

gan Pulte, Dianne, Olson, Kim E, Broekman, M Johan, Islam, Naziba, Ballard, Harold S, Furman, Richard R, Olson, Ashley E, Marcus, Aaron J
Cyhoeddwyd 2007

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas

gan Martin, Peter, Furman, Richard R., Rutherford, Sarah, Ruan, Jia, Ely, Scott, Greenberg, June, Coleman, Morton, Goldsmith, Stanley J., Leonard, John P.
Cyhoeddwyd yn Leuk Lymphoma (2015)

Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia

gan Simon, Matthew S, Westblade, Lars F, Dziedziech, Alexis, Visone, Joseph E, Furman, Richard R, Jenkins, Stephen G, Schuetz, Audrey N, Kirkman, Laura A
Cyhoeddwyd yn Clin Infect Dis (2017)

Durable Responses with the Metronomic Regimen RT-PEPC in Elderly Patients with Recurrent Mantle Cell Lymphoma

gan Ruan, Jia, Martin, Peter, Coleman, Morton, Furman, Richard R., Cheung, Ken, Faye, Adam, Elstrom, Rebecca, Lachs, Mark, Hajjar, Katherine A., Leonard, John P.
Cyhoeddwyd 2010

CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia

gan Pulte, Dianne, Furman, Richard R., Broekman, M. Johan, Drosopoulos, Joan H. F., Ballard, Harold S., Olson, Kim E., Kizer, Jorge R., Marcus, Aaron J.
Cyhoeddwyd 2011

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

gan Ghia, Paolo, Coutre, Steven E., Cheson, Bruce D., Barrientos, Jacqueline C., Hillmen, Peter, Pettitt, Andrew R., Zelenetz, Andrew D., Shreay, Sanatan, Hallek, Michael, Furman, Richard R.
Cyhoeddwyd yn Haematologica (2020)

Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor

gan Vaisitti, Tiziana, Gaudino, Federica, Ouk, Samedy, Moscvin, Maria, Vitale, Nicoletta, Serra, Sara, Arruga, Francesca, Zakrzewski, Johannes L., Liou, Hsiou-Chi, Allan, John N., Furman, Richard R., Deaglio, Silvia
Cyhoeddwyd yn Haematologica (2017)

Evaluation of the CLL-IPI in Relapsed and Refractory Chronic Lymphocytic Leukemia in Idelalisib Phase 3 Trials

gan Soumerai, Jacob D., Ni, Ai, Xing, Guan, Huang, Julie, Furman, Richard R., Jones, Jeffrey, Sharman, Jeffrey P., Hallek, Michael, Adewoye, Adeboye H., Dubowy, Ronald, Dreiling, Lyndah, Zelenetz, Andrew D.
Cyhoeddwyd yn Leuk Lymphoma (2018)

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor

gan Wierda, William G., Byrd, John C., Davids, Matthew S., Furman, Richard R., Cheson, Bruce D., Barr, Paul M., Eradat, Herbert, Heffner, Leonard, Zhou, Lang, Verdugo, Maria, Potluri, Jalaja, Choi, Michael
Cyhoeddwyd yn Br J Haematol (2018)

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

gan Ruan, Jia, Martin, Peter, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Furman, Richard R., Christos, Paul, Rodriguez, Amelyn, Svoboda, Jakub, Lewis, Jessica, Katz, Orel, Coleman, Morton, Leonard, John P.
Cyhoeddwyd yn N Engl J Med (2015)

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL and CD40L

gan Cols, Montserrat, Barra, Carolina M., He, Bing, Puga, Irene, Xu, Weifeng, Chiu, April, Tam, Wayne, Knowles, Daniel M., Dillon, Stacey R., Leonard, John P., Furman, Richard R., Chen, Kang, Cerutti, Andrea
Cyhoeddwyd 2012

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

gan Furman, Richard R., Cheng, Shuhua, Lu, Pin, Setty, Menu, Perez, Alexendar R., Guo, Ailin, Racchumi, Joelle, Xu, Guozhou, Wu, Hao, Ma, Jiao, Steggerda, Susanne M., Coleman, Morton, Leslie, Christina, Wang, Y. Lynn
Cyhoeddwyd yn N Engl J Med (2014)

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

gan Bologna, Cinzia, Buonincontri, Roberta, Serra, Sara, Vaisitti, Tiziana, Audrito, Valentina, Brusa, Davide, Pagnani, Andrea, Coscia, Marta, D’Arena, Giovanni, Mereu, Elisabetta, Piva, Roberto, Furman, Richard R., Rossi, Davide, Gaidano, Gianluca, Terhorst, Cox, Deaglio, Silvia
Cyhoeddwyd yn J Clin Invest (2015)